Skip to main content
. 2020 Dec 8;2020(12):CD013432. doi: 10.1002/14651858.CD013432.pub2
Study Reason for exclusion
Condreay 2019 Investigation of genetic associations with frequency of moderate or severe COPD exacerbations (or both) in COPD participants receiving mepolizumab. Not a randomised trial
Sridhar 2019 Aggregation of 2 studies investigating modulation of blood inflammatory markers

COPD: chronic obstructive pulmonary disease